RadNet, Inc. (RDNT)
USD 72.41
(-5.37%)
USD 72.41
(-5.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 93 Million USD | -43.88% |
| 2022 | 165.71 Million USD | -13.6% |
| 2021 | 191.8 Million USD | 81.05% |
| 2020 | 105.93 Million USD | -31.43% |
| 2019 | 154.48 Million USD | 43.58% |
| 2018 | 107.59 Million USD | -10.19% |
| 2017 | 119.8 Million USD | 10.19% |
| 2016 | 108.73 Million USD | 7.3% |
| 2015 | 101.33 Million USD | -11.82% |
| 2014 | 114.91 Million USD | 10.15% |
| 2013 | 104.33 Million USD | 0.16% |
| 2012 | 104.16 Million USD | -26.63% |
| 2011 | 141.97 Million USD | 11.29% |
| 2010 | 127.56 Million USD | 0.75% |
| 2009 | 126.61 Million USD | 7.46% |
| 2008 | 117.82 Million USD | 24.13% |
| 2007 | 94.92 Million USD | 133.43% |
| 2006 | 40.66 Million USD | 11.22% |
| 2005 | 36.56 Million USD | 16.25% |
| 2004 | 31.44 Million USD | -7.99% |
| 2003 | 34.18 Million USD | 1.1% |
| 2002 | 33.8 Million USD | -0.06% |
| 2001 | 33.82 Million USD | 30.36% |
| 2000 | 25.95 Million USD | 99.62% |
| 1999 | 13 Million USD | -77.9% |
| 1998 | 58.82 Million USD | -12.23% |
| 1997 | 67.01 Million USD | 18.54% |
| 1996 | 56.53 Million USD | 24.69% |
| 1995 | 45.34 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 11.75 Million USD | -62.22% |
| 2024 Q2 | 35.51 Million USD | 202.26% |
| 2023 FY | 93 Million USD | -43.88% |
| 2023 Q1 | 38.69 Million USD | -28.71% |
| 2023 Q3 | 60.33 Million USD | 3.01% |
| 2023 Q4 | 31.1 Million USD | -48.44% |
| 2023 Q2 | 58.56 Million USD | 51.34% |
| 2022 Q2 | 48.6 Million USD | 81.83% |
| 2022 Q4 | 54.28 Million USD | 50.37% |
| 2022 Q3 | 36.1 Million USD | -25.72% |
| 2022 FY | 165.71 Million USD | -13.6% |
| 2022 Q1 | 26.72 Million USD | -44.87% |
| 2021 Q4 | 48.48 Million USD | -19.11% |
| 2021 Q1 | 33.03 Million USD | -34.83% |
| 2021 Q2 | 50.34 Million USD | 52.39% |
| 2021 FY | 191.8 Million USD | 81.05% |
| 2021 Q3 | 59.93 Million USD | 19.04% |
| 2020 Q4 | 50.69 Million USD | 11.87% |
| 2020 Q3 | 45.31 Million USD | 1341.14% |
| 2020 Q2 | -3.65 Million USD | -125.81% |
| 2020 FY | 105.93 Million USD | -31.43% |
| 2020 Q1 | 14.14 Million USD | -68.66% |
| 2019 Q3 | 38.3 Million USD | -9.94% |
| 2019 Q2 | 42.53 Million USD | 49.3% |
| 2019 Q1 | 28.49 Million USD | 19.4% |
| 2019 FY | 154.48 Million USD | 43.58% |
| 2019 Q4 | 45.14 Million USD | 17.85% |
| 2018 Q4 | 23.86 Million USD | -29.05% |
| 2018 FY | 107.59 Million USD | -10.19% |
| 2018 Q1 | 15.75 Million USD | -55.42% |
| 2018 Q2 | 34.34 Million USD | 117.92% |
| 2018 Q3 | 33.63 Million USD | -2.05% |
| 2017 Q2 | 31.4 Million USD | 33.3% |
| 2017 Q4 | 35.34 Million USD | 19.83% |
| 2017 Q3 | 29.49 Million USD | -6.07% |
| 2017 Q1 | 23.55 Million USD | -28.13% |
| 2017 FY | 119.8 Million USD | 10.19% |
| 2016 FY | 108.73 Million USD | 7.3% |
| 2016 Q1 | 19.56 Million USD | -29.54% |
| 2016 Q2 | 24.5 Million USD | 25.26% |
| 2016 Q3 | 31.89 Million USD | 30.15% |
| 2016 Q4 | 32.77 Million USD | 2.78% |
| 2015 FY | 101.33 Million USD | -11.82% |
| 2015 Q2 | 28.49 Million USD | 130.79% |
| 2015 Q3 | 32.73 Million USD | 14.89% |
| 2015 Q4 | 27.76 Million USD | -15.18% |
| 2015 Q1 | 12.34 Million USD | -57.04% |
| 2014 Q2 | 31.27 Million USD | 31.15% |
| 2014 Q1 | 23.84 Million USD | -19.75% |
| 2014 FY | 114.91 Million USD | 10.15% |
| 2014 Q4 | 28.73 Million USD | -7.47% |
| 2014 Q3 | 31.05 Million USD | -0.69% |
| 2013 Q1 | 23.37 Million USD | 8.65% |
| 2013 FY | 104.33 Million USD | 0.16% |
| 2013 Q4 | 29.71 Million USD | 26.88% |
| 2013 Q2 | 27.82 Million USD | 19.01% |
| 2013 Q3 | 23.41 Million USD | -15.83% |
| 2012 Q4 | 21.51 Million USD | -20.98% |
| 2012 Q1 | 26.61 Million USD | -36.58% |
| 2012 Q2 | 28.79 Million USD | 8.19% |
| 2012 Q3 | 27.23 Million USD | -5.44% |
| 2012 FY | 104.16 Million USD | -26.63% |
| 2011 Q2 | 36.51 Million USD | 20.17% |
| 2011 FY | 141.97 Million USD | 11.29% |
| 2011 Q4 | 41.96 Million USD | 26.8% |
| 2011 Q3 | 33.09 Million USD | -9.37% |
| 2011 Q1 | 30.38 Million USD | -15.16% |
| 2010 FY | 127.56 Million USD | 0.75% |
| 2010 Q3 | 33.45 Million USD | 2.18% |
| 2010 Q1 | 25.53 Million USD | -21.93% |
| 2010 Q2 | 32.74 Million USD | 28.22% |
| 2010 Q4 | 35.82 Million USD | 7.06% |
| 2009 Q2 | 31.43 Million USD | 1.42% |
| 2009 FY | 126.61 Million USD | 7.46% |
| 2009 Q1 | 30.99 Million USD | 2.06% |
| 2009 Q4 | 32.71 Million USD | 3.92% |
| 2009 Q3 | 31.48 Million USD | 0.16% |
| 2008 Q2 | 29.56 Million USD | 14.88% |
| 2008 FY | 117.82 Million USD | 24.13% |
| 2008 Q3 | 32.16 Million USD | 8.81% |
| 2008 Q4 | 30.36 Million USD | -5.6% |
| 2008 Q1 | 25.73 Million USD | 58.12% |
| 2007 Q2 | 27.88 Million USD | 14.22% |
| 2007 FY | 94.92 Million USD | 133.43% |
| 2007 Q1 | 24.41 Million USD | 0.0% |
| 2007 Q3 | 26.7 Million USD | -4.23% |
| 2007 Q4 | 16.27 Million USD | -39.06% |
| 2006 FY | 40.66 Million USD | 11.22% |
| 2006 Q2 | 10.23 Million USD | 0.69% |
| 2006 Q1 | 10.16 Million USD | 8.45% |
| 2006 Q3 | 10.9 Million USD | 6.56% |
| 2005 Q2 | 9.38 Million USD | 3.7% |
| 2005 Q4 | 9.36 Million USD | -13.85% |
| 2005 Q1 | 9.05 Million USD | 24.96% |
| 2005 FY | 36.56 Million USD | 16.25% |
| 2005 Q3 | 10.87 Million USD | 15.84% |
| 2004 Q2 | 6.86 Million USD | -16.05% |
| 2004 FY | 31.44 Million USD | -7.99% |
| 2004 Q4 | 7.24 Million USD | 2.77% |
| 2004 Q1 | 8.17 Million USD | -4.79% |
| 2004 Q3 | 7.05 Million USD | 2.75% |
| 2003 Q2 | 9.93 Million USD | 2.77% |
| 2003 Q3 | 5.71 Million USD | -42.5% |
| 2003 Q4 | 8.58 Million USD | 50.33% |
| 2003 Q1 | 9.66 Million USD | 8.82% |
| 2003 FY | 34.18 Million USD | 1.1% |
| 2002 Q3 | 8.84 Million USD | 42.26% |
| 2002 Q4 | 8.87 Million USD | 0.36% |
| 2002 FY | 33.8 Million USD | -0.06% |
| 2002 Q1 | 9.87 Million USD | 11.3% |
| 2002 Q2 | 6.21 Million USD | -37.0% |
| 2001 Q2 | 8.94 Million USD | 9.85% |
| 2001 Q4 | 8.87 Million USD | -6.7% |
| 2001 Q3 | 9.5 Million USD | 6.31% |
| 2001 Q1 | 8.14 Million USD | 12.46% |
| 2001 FY | 33.82 Million USD | 30.36% |
| 2000 Q2 | 7.58 Million USD | 12.32% |
| 2000 Q1 | 6.75 Million USD | 20.65% |
| 2000 FY | 25.95 Million USD | 99.62% |
| 2000 Q4 | 7.23 Million USD | 20.54% |
| 2000 Q3 | 6 Million USD | -20.87% |
| 1999 Q1 | 3.2 Million USD | 68.42% |
| 1999 Q3 | 4.1 Million USD | 2.5% |
| 1999 FY | 13 Million USD | -77.9% |
| 1999 Q2 | 4 Million USD | 25.0% |
| 1999 Q4 | 5.6 Million USD | 36.59% |
| 1998 Q3 | -500 Thousand USD | -116.13% |
| 1998 Q2 | 3.1 Million USD | 6.9% |
| 1998 Q4 | 1.9 Million USD | 480.0% |
| 1998 FY | 58.82 Million USD | -12.23% |
| 1998 Q1 | 2.9 Million USD | 38.1% |
| 1997 Q2 | 2.4 Million USD | -7.69% |
| 1997 Q3 | 600 Thousand USD | -75.0% |
| 1997 Q4 | 2.1 Million USD | 250.0% |
| 1997 FY | 67.01 Million USD | 18.54% |
| 1997 Q1 | 2.6 Million USD | -3.7% |
| 1996 FY | 56.53 Million USD | 24.69% |
| 1996 Q3 | -100 Thousand USD | -106.67% |
| 1996 Q2 | 1.5 Million USD | -50.0% |
| 1996 Q1 | 3 Million USD | 0.0% |
| 1996 Q4 | 2.7 Million USD | 2800.0% |
| 1995 FY | 45.34 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -872.193% |
| Prenetics Global Limited | 8.82 Million USD | -953.241% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -679.809% |
| CareDx, Inc | 178.32 Million USD | 47.848% |
| Exact Sciences Corporation | 1.84 Billion USD | 94.961% |
| Exagen Inc. | 29.45 Million USD | -215.725% |
| Inotiv, Inc. | 165.44 Million USD | 43.787% |
| Guardant Health, Inc. | 336.89 Million USD | 72.395% |
| Biodesix, Inc. | 36.07 Million USD | -157.782% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -6895.121% |
| Precipio, Inc. | 6.01 Million USD | -1445.364% |
| iSpecimen Inc. | 5.1 Million USD | -1720.703% |
| Natera, Inc. | 492.74 Million USD | 81.126% |
| Aspira Women's Health Inc. | 5.26 Million USD | -1667.389% |
| Standard BioTools Inc. | 50.45 Million USD | -84.341% |
| 23andMe Holding Co. | 99.37 Million USD | 6.417% |
| Castle Biosciences, Inc. | 174.8 Million USD | 46.798% |
| Personalis, Inc. | 18.2 Million USD | -410.764% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -606.258% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -1580.693% |
| OpGen, Inc. | -90.69 Thousand USD | 102642.616% |
| T2 Biosystems, Inc. | -8.17 Million USD | 1238.311% |
| Myriad Genetics, Inc. | 476.4 Million USD | 80.479% |
| ICON Public Limited Company | 1.81 Billion USD | 94.874% |
| NeoGenomics, Inc. | 244.6 Million USD | 61.979% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -679.809% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 95.753% |
| MDxHealth SA | 43.92 Million USD | -111.705% |
| Psychemedics Corporation | 8.41 Million USD | -1005.432% |
| Illumina, Inc. | 2.74 Billion USD | 96.611% |
| Check-Cap Ltd. | -212 Thousand USD | 43967.925% |
| Twist Bioscience Corporation | 133.34 Million USD | 30.258% |
| DarioHealth Corp. | 5.98 Million USD | -1454.144% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 10.967% |
| Sera Prognostics, Inc. | 96 Thousand USD | -96775.0% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 33862.811% |
| OPKO Health, Inc. | 318.12 Million USD | 70.766% |
| Medpace Holdings, Inc. | 524.5 Million USD | 82.269% |
| Neogen Corporation | 463.9 Million USD | 79.953% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -6423.45% |
| Prenetics Global Limited | 8.82 Million USD | -953.241% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -18147.495% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -11648.135% |
| Trinity Biotech plc | 19.45 Million USD | -378.149% |
| Neuronetics, Inc. | 51.7 Million USD | -79.867% |
| Sotera Health Company | 577.15 Million USD | 83.887% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -11648.135% |